AHK-Cu is een complex van het tripeptide Ala-His-Lys met tweewaardig koper. Het minder onderzochte broertje van GHK-Cu, dat vooral wordt gebruikt in modellen voor de stimulatie van haarzakjes en de regeneratie van haarvaten. Wordt toegepast in onderzoek naar de inductie van de anagene fase, de microcirculatie in de huid en koperafhankelijke enzymatische systemen (lysyloxidase). CAS 76172-39-7, MW 443 Da, zuiverheid ≥99% volgens HPLC.
Prijs: EUR 69.00 | Merk: PEPTEX | Op voorraad | EU-brede levering, binnen 7 werkdagen
Beoordeling: 4.9/5 (305 beoordelingen)
Klantbeoordelingen
Дмитрий В. — ★★★★★ Simple and clear order interface.
Ines T. — ★★★★★ Vial intact, packaging reliable. Contents undamaged.
Beschikbare maten
100mg — 69 EUR
PEPTEX levert in Nederland en België — snelle verzending, gecertificeerde kwaliteit, gratis levering boven 150 €.
By entering the PEPTEX website, I confirm that I am at least 18 years old and that I am considering these products solely for research and laboratory purposes.
All products are intended for scientific research and not for human or animal consumption.
Third-party laboratory Certificates of Analysis (COA) for every PEPTEX peptide
Why transparency matters
Research-grade peptides require verified identity and purity. An unverified vial is an unverified experiment.
A Certificate of Analysis (COA) is available on every product page.
Testing methodology
Identity confirmation by mass spectrometry, purity assay, appearance check, and moisture content. Reports issued by EU-based accredited laboratories.
Every PEPTEX product has an independent Certificate of Analysis available on its product page. All products meet or exceed ≥99% purity — no exceptions.
Browse certificates by product
Frequently asked questions
What does ≥99% purity mean?
It means that at least 99% of the powder is the target peptide.
How is the batch linked to the COA?
Every vial carries a batch number matching the COA.
Can I verify the COA independently?
Yes — each COA carries the issuing laboratory name and report ID.
💬 Комментарии